Advertisement
Screener

BOUNDLESS BIO, INC. (BOLD) ROA

Boundless Bio, Inc. ROA

Return on assets (ROA) is the profit a company earns for every dollar of assets it uses, shown as a percentage. It is net income divided by total assets, and the table shows both amounts. Because assets are funded by lenders as well as shareholders, ROA is not inflated by borrowing the way ROE can be, and it is naturally lower for businesses that need many factories, stores or other assets. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • Boundless Bio, Inc. roa for the quarter ending 2026-06-30 was -86.80%, a change of -50.92% year-over-year.
  • Boundless Bio, Inc. roa for the quarter ending 2026-03-31 was -39.72%, a change of -5.37% year-over-year.
  • Boundless Bio, Inc. roa for the quarter ending 2025-12-31 was -37.05%, a change of -5.39% year-over-year.
  • Boundless Bio, Inc. roa for the quarter ending 2025-09-30 was -36.60%, a change of -1.73% year-over-year.
  • Boundless Bio, Inc. roa for fiscal 2025 was -37.05%, a change of -5.39% from fiscal 2024.
  • Boundless Bio, Inc. roa for fiscal 2024 was -31.67%, a change of 6.39% from fiscal 2023.
  • Boundless Bio, Inc. roa for fiscal 2023 was -38.06%.
Available history
2023-12-31 to 2026-06-30
Data captured

Historical ROA

DateROANet income 12 monthNet income 3 monthTotal assets
2026-06-30-86.80%-$64.01M-$23.69M$73.74M
2026-03-31-39.72%-$55.99M-$13.55M$140.97M
2025-12-31-37.05%-$58.2M-$12.88M$157.06M
2025-09-30-36.60%-$61.76M-$13.88M$168.72M
2025-06-30-35.88%-$64.39M-$15.68M$179.45M
2025-03-31-34.35%-$65.69M-$15.76M$191.24M
2024-12-31-31.67%-$65.36M-$16.45M$206.41M
2024-09-30-34.87%-$61.06M-$16.51M$175.09M
2024-06-30-30.67%-$57.72M-$16.98M$188.2M
2024-03-31-45.39%-$53.15M-$15.43M$117.08M
2023-12-31-38.06%-$49.43M-$12.14M$129.89M

Annual ROA

DateROANet income 12 monthTotal assets
2025-12-31-37.05%-$58.2M$157.06M
2024-12-31-31.67%-$65.36M$206.41M
2023-12-31-38.06%-$49.43M$129.89M

Similar stocks

Stock NameCountryMarket CapPE Ratio
NOMAD POWER SOLUTIONS, INC. (NMAD)United States$0.058B
TALPHERA, INC. (TLPH)United States$0.060B
CalciMedica, Inc. (CALC)United States$0.061B-1.42
Skye Bioscience, Inc. (SKYE)United States$0.061B-0.48
Annovis Bio, Inc. (ANVS)United States$0.056B-1.58
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
Clene Inc. (CLNN)United States$0.054B-1.99
Serina Therapeutics, Inc. (SER)United States$0.054B-2.35
HYPERION DEFI, INC. (HYPD)United States$0.065B